Ind Swift Ltd INDSWFTLTD-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 08/03/21 IST
7.95UNCH (UNCH)
52 week range
2.25 - 7.95

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.95
  • 52 Week High7.95
  • 52 Week High Date08/03/21
  • 52 Week Low2.25
  • 52 Week Low Date08/04/20

Key Stats

  • Market Cap5.28M
  • Shares Out54.16M
  • 10 Day Average Volume3,116.71
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change114.86

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.95
  • 52 Week High7.95
  • 52 Week High Date08/03/21
  • 52 Week Low2.25
  • 52 Week Low Date08/04/20
  • Market Cap5.28M
  • Shares Out54.16M
  • 10 Day Average Volume3,116.71
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change114.86

RATIOS/PROFITABILITY

  • EPS (TTM)-5.51
  • P/E (TTM)-1.44
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ind Swift Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ind-Swift Limited is a manufacturer of formulations. The Company operates through pharmaceutical products segment. Its geographic segments include domestic and export. The Company has a portfolio of over 750 products in therapeutic segments, such as cardiology, diabetology, anti-depressant, anti-allergic, anti-infective, neurology, oncology and dermatology. Its portfolio of active pharmaceutical ingredients (APIs) in pipeline include Fluvastatin; Risedronate; Ezetimibe;...
Sanjeev Mehta
Chairman
Gopal Munjal
Chief Executive Officer
Amit Tarafder
Vice President - Finance
Address
781, Industrial Area,Phase II,
Chandigarh
160002
India